Citadel Advisors
GRI

Citadel Advisors’s GRI Bio GRI Stock Holding History

Citadel Advisors’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Buy
+13,376
New +$29.6K ﹤0.01% 13365
2024
Q1 		– Sell
-2
Closed -$33K – 14901
2023
Q4 		$33K Buy
+2
New +$83.4K ﹤0.01% 12190
2023
Q2 		– Hold
0
– -$4.01K – 14676
2023
Q1 		– Hold
0
– – – 13995

Other funds holding GRI

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Citadel Advisors's GRI Position: Q2 2026 in Review

Citadel Advisors opened a new position in GRI Bio (GRI) in Q2 2026: 13,376 shares worth $23.7K. The stake represents ﹤0.01% of the portfolio and ranks #13365 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in GRI as recently as Q4 2023.

Citadel Advisors first reported a position in GRI in Q4 2023 and has held it in 2 quarters since. The position peaked at $33K in Q4 2023. 11 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • Citadel Advisors held 13,376 shares of GRI Bio worth $23.7K as of Q2 2026.
  • GRI Bio was a new Citadel Advisors position in Q2 2026.
  • GRI Bio made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13365 holding.
  • Citadel Advisors first reported a position in GRI Bio in Q4 2023 and has held it in 2 quarters since.
  • Citadel Advisors's GRI Bio position peaked at $33K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.